CINECA IRIS Institutional Research Information System

CAPELLO, Michela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.637
EU - Europa 1.927
AS - Asia 1.847
SA - Sud America 161
AF - Africa 58
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 8
Totale 7.675
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.565
SG - Singapore 673
CN - Cina 612
IT - Italia 463
DK - Danimarca 237
SE - Svezia 222
VN - Vietnam 184
DE - Germania 141
IE - Irlanda 138
BR - Brasile 132
FR - Francia 125
AT - Austria 124
UA - Ucraina 110
FI - Finlandia 104
GB - Regno Unito 88
KR - Corea 59
HK - Hong Kong 54
PL - Polonia 54
JP - Giappone 52
IN - India 49
TW - Taiwan 49
CA - Canada 47
SN - Senegal 38
AU - Australia 36
NL - Olanda 23
ID - Indonesia 21
BE - Belgio 20
RU - Federazione Russa 20
IQ - Iraq 18
PK - Pakistan 12
UZ - Uzbekistan 12
BY - Bielorussia 11
ES - Italia 11
TR - Turchia 11
MX - Messico 10
ZA - Sudafrica 9
AR - Argentina 8
BD - Bangladesh 8
RO - Romania 8
EU - Europa 7
CH - Svizzera 5
CL - Cile 5
CZ - Repubblica Ceca 5
JM - Giamaica 5
PH - Filippine 5
CO - Colombia 4
MY - Malesia 4
DZ - Algeria 3
EC - Ecuador 3
IL - Israele 3
JO - Giordania 3
PE - Perù 3
VE - Venezuela 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
CY - Cipro 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
MA - Marocco 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BS - Bahamas 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MT - Malta 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.675
Salva come PNG Salva come JPEG
Città #
Chandler 400
Singapore 368
Ann Arbor 322
Beijing 302
Ashburn 270
San Jose 153
Wilmington 147
Houston 139
Dublin 137
Dearborn 135
Santa Clara 130
Vienna 122
Fairfield 114
Nyköping 83
Jacksonville 82
Woodbridge 70
Guangzhou 64
Seattle 60
Cambridge 50
Ho Chi Minh City 50
Milan 50
Warsaw 49
Medford 48
Los Angeles 47
Villeurbanne 45
Princeton 44
Torino 44
Turin 43
Hong Kong 41
Fremont 40
The Dalles 40
Hanoi 37
Lauterbourg 37
Columbus 36
Taipei 35
Dallas 34
Tokyo 33
Pisa 32
Rome 31
Redwood City 27
Boardman 26
Munich 26
Dong Ket 24
Orem 24
Shanghai 23
Buffalo 20
Washington 19
Boston 18
Brussels 18
New York 18
Norwalk 18
Phoenix 18
Helsinki 17
San Mateo 16
Nanjing 15
Chengdu 13
London 13
Turku 13
Jakarta 12
Nuremberg 12
Seoul 12
Atlanta 11
Chennai 11
Naples 11
Toronto 11
Wuhan 11
Frankfurt am Main 10
Manchester 10
Wayne 10
Melbourne 9
Shenyang 9
Zhengzhou 9
Baghdad 8
Falls Church 8
Haiphong 8
Lincoln 8
Mumbai 8
Paris 8
San Diego 8
Amsterdam 7
Brooklyn 7
Chicago 7
Figino 7
Halmstad 7
Montreal 7
Provo 7
São Paulo 7
Bologna 6
Falkenstein 6
Hefei 6
Heidelberg 6
Changchun 5
Da Nang 5
Düsseldorf 5
Florence 5
Genoa 5
Ichikawa 5
Jinan 5
Johannesburg 5
Kunming 5
Totale 4.659
Salva come PNG Salva come JPEG
Nome #
Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer. 523
Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers 395
Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation. 387
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis 387
α-enolase: a promising therapeutic and diagnostic tumor target 309
Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients 301
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest 300
Chemotherapy effects on immune-complexes in pancreatic ductal adenocarcinoma patients serum 290
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. 263
Proteomic data analysis of pancreatic cancer patient sera revealed how chemotherapy shapes the immunogenicity of developing tumors 260
An integrative transcriptomic analysis of glycolytic genes reveals distinct metabolic subtypes in pancreatic cancer 241
Three are better than one: plasminogen receptors as cancer theranostic targets. 219
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) 202
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 201
A Mouse To Human Autoantibody Signature in Pancreatic Ductal Adenocarcinoma 189
Autoantibody signature in human ductal pancreatic adenocarcinoma 186
Alpha-enolase elicits specific adenocarcinoma pancreatic-T cell responses in healthy donors and tumor patients 186
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth 181
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia 164
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA 163
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) 157
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA 154
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) 152
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia 148
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 147
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 138
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis (SERPA) 138
Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes 133
Mass spectrometry analysis reveals novel O-methylation of L-lactate dehydrogenase from pancreatic ductal adenocarcinoma cells 132
Serological proteome analysis (SERPA) as a tool for the identification of tumor antigens capable of eliciting immune responses in chronic lymphocytic leukemia (CLL) 132
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA 132
QUARTZ CRYSTAL MICROBALANCE WITH DISSIPATION (QCM-D) AS TOOL TO EXPLOIT ANTIGEN-ANTIBODY INTERACTIONS IN PANCREATIC DUCTAL ADENOCARCINOMA DETECTION 127
Towards pancreatic cancer diagnosis using EIS biochips. 120
PHOSPHOPROTEOMIC ANALYSIS OF PANCREATIC DUCTAL ADENOCARCINOMA CELLS REVEALS DIFFERENTIAL PHOSPHORYLATION OF CELL ADHESION, CELL JUNCTION AND STRUCTURAL PROTEINS 115
Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells 112
A method and a kit for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinoma 110
Mass spectrometric analysis reveals O-methylation of pyruvate kinase from pancreatic cancer cells. 102
Proteomic Analysis Reveals Warburg Effect and Anomalous Metabolism of Glutamine in Pancreatic Cancer Cells 98
Proteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Metabolic Alterations. 92
Procedimento e kit per la diagnosi in vitro dell’adenocarcinoma duttale pancreatico o per determinare la predisposizione all’adenocarcinoma duttale pancreatico 88
Totale 7.874
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.106
article - articoli 0
book - libri 0
conference - conferenze 9.103
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.209
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022608 20 17 18 35 22 35 57 32 23 58 168 123
2022/2023946 80 98 17 131 92 216 50 73 109 20 40 20
2023/2024334 62 51 30 20 10 57 4 29 2 12 19 38
2024/2025890 13 29 32 95 212 61 27 46 118 48 71 138
2025/20261.881 218 48 91 163 207 86 324 71 195 115 74 289
2026/202737 37 0 0 0 0 0 0 0 0 0 0 0
Totale 7.874